Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujit Sheth

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Lancet (London, England)|June 22, 2025
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trialAli T Taher, Hanny Al-Samkari, Yesim Aydinok, et al.
The Lancet. Haematology|February 8, 2024
Diagnosis and management of pyruvate kinase deficiency: international expert guidelinesHanny Al-Samkari, Nadine Shehata, Kelly Lang-Robertson, et al.
American Journal of Hematology|July 4, 2020
Characterization of the severe phenotype of pyruvate kinase deficiencyHanny Al-Samkari, Eduard J van Beers, D Holmes Morton, et al.
Haematologica|September 15, 2018
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History StudyEduard J van Beers, Stephanie van Straaten, D Holmes Morton, et al.
Blood|March 18, 2018
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History StudyRachael F Grace, Paola Bianchi, Eduard J van Beers, et al.
Cell|August 16, 2020
Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Lancet (London, England)|June 22, 2025
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trialAli T Taher, Hanny Al-Samkari, Yesim Aydinok, et al.
The Lancet. Haematology|February 8, 2024
Diagnosis and management of pyruvate kinase deficiency: international expert guidelinesHanny Al-Samkari, Nadine Shehata, Kelly Lang-Robertson, et al.
American Journal of Hematology|July 4, 2020
Characterization of the severe phenotype of pyruvate kinase deficiencyHanny Al-Samkari, Eduard J van Beers, D Holmes Morton, et al.
Haematologica|September 15, 2018
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History StudyEduard J van Beers, Stephanie van Straaten, D Holmes Morton, et al.
Blood|March 18, 2018
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History StudyRachael F Grace, Paola Bianchi, Eduard J van Beers, et al.
Cell|August 16, 2020
Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Pageof 7